St. Jude Medical, Inc. (STJ: Quote) announced CE Mark Approval of the Ellipse implantable cardioverter defibrillator, or ICD. ICDs are advanced implantable cardiac devices that treat potentially lethal, abnormally fast heart rhythms that often lead to sudden cardiac death.
According to the company, the Ellipse ICD provides the benefits of advanced features and power in the industry's smallest high-energy ICD.
Dr. L.R.C. Dekker, cardiologist from the Cardiac Center of the Catharina Hospital in Eindhoven, The Netherlands, who implanted the first Ellipse ICD in Europe, said, "Its thinness, longevity and new discrimination algorithms constitute the answers to the three main concerns of patients and their doctors: decreasing the volume of the can, reducing the risk for infection during ICD replacement and minimizing inappropriate shock."
Click here to receive FREE breaking news email alerts for St. Jude Medical Inc. and others in your portfolio
by RTT Staff Writer
For comments and feedback: editorial@rttnews.com
Business News